GFAFX
Price
$71.96
Change
+$0.53 (+0.74%)
Updated
May 8 closing price
Net Assets
283.8B
GSCLX
Price
$26.93
Change
+$0.24 (+0.90%)
Updated
May 8 closing price
Net Assets
1.36B
Ad is loading...

GFAFX vs GSCLX

Header iconGFAFX vs GSCLX Comparison
Open Charts GFAFX vs GSCLXBanner chart's image
American Funds Growth Fund of Amer F1
Price$71.96
Change+$0.53 (+0.74%)
VolumeN/A
Net Assets283.8B
Goldman Sachs Large Cap Gr Insghts Svc
Price$26.93
Change+$0.24 (+0.90%)
VolumeN/A
Net Assets1.36B
GFAFX vs GSCLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFAFX vs. GSCLX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFAFX is a StrongBuy and GSCLX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFAFX has more cash in the bank: 284B vs. GSCLX (1.36B). GFAFX pays higher dividends than GSCLX: GFAFX (0.35) vs GSCLX (0.00). GFAFX was incepted earlier than GSCLX: GFAFX (24 years) vs GSCLX (28 years). GSCLX (1.09) is less costly to investors than GFAFX (0.67). GSCLX is a more actively managed with annual turnover of: 215.00 vs. GFAFX (25.00). GSCLX has a lower initial minimum investment than GFAFX: GSCLX (0) vs GFAFX (250). GFAFX annual gain was more profitable for investors over the last year : 3.57 vs. GSCLX (-3.38). GFAFX return over 5 years is better than : 44.32 vs. GSCLX (-15.31).
GFAFXGSCLXGFAFX / GSCLX
Total Expense Ratio0.671.0663%
Annual Report Gross Expense Ratio0.671.0961%
Fund Existence24 years28 years-
Gain YTD-2.440-9.49026%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets284B1.36B20,913%
Annual Yield % from dividends0.350.00-
Returns for 1 year3.57-3.38-106%
Returns for 3 years34.102.101,621%
Returns for 5 years44.32-15.31-289%
Returns for 10 years61.3218.01341%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTRS8.600.12
+1.42%
Viatris
FDMT3.120.04
+1.14%
4D Molecular Therapeutics
ICFI84.38-0.08
-0.09%
ICF International
AIMD0.54N/A
-0.19%
Ainos
NAGE8.45-0.28
-3.21%
Niagen Bioscience Inc